• Evaluate three capital projects using NPV, IRR, payback, and PI to recommend the one maximizing shareholder value in healthcare.

• Critique project cash flows under varying discount rates, recommending the least value-destructive option.

• Develop a report analyzing cash flows and budgeting metrics for equipment, expansion, and marketing investments.

Evaluating Capital Projects in Healthcare: NPV, IRR, and Beyond – Sample Paper

Evaluation of Capital Projects in ABC Healthcare Corporation

Capital allocation decisions shape a company’s future. Finance managers at firms like ABC Healthcare Corporation must weigh options carefully. They forecast cash flows and apply budgeting metrics to spot opportunities that boost shareholder value. This report examines three proposed projects: a major equipment purchase (Project A), expansion into three states (Project B), and a marketing campaign (Project C). Each involves upfront costs and projected returns. I computed cash flows based on given details, including sales growth, tax effects, and depreciation where applicable. Then, I used four tools—net present value (NPV), internal rate of return (IRR), payback period, and profitability index (PI)—to assess them. Although all projects show negative NPVs, Project C delivers the highest value among them. It minimizes losses while offering moderate risk. Senior leaders can use this analysis to decide. Non-finance stakeholders will find the metrics explained simply, with real numbers from the computations.

Capital budgeting tools help compare projects. Managers pick the one that maximizes wealth. NPV tops the list because it directly measures value added in dollars (Al-Omush et al., 2024). IRR shows the project’s implied return rate. Payback period tracks recovery time. PI compares benefits to costs. Each tool guides accept or reject decisions. Positive results signal go-ahead; negative ones suggest caution.

NPV discounts future cash flows to today’s dollars. It subtracts initial costs from the present value of inflows. A positive NPV means the project earns more than the required return. For instance, if NPV exceeds zero at 8% discount, accept it. This aligns with shareholder goals, as extra value flows to owners (Gordon and Zhu, 2023). Negative NPV, however, warns of destruction in value. Companies reject such projects unless strategic needs override.

IRR finds the discount rate that sets NPV to zero. It represents the project’s break-even return. Accept if IRR tops the cost of capital, like 10% hurdle. This metric shines for quick comparisons. However, it can mislead with non-conventional cash flows, such as multiple sign changes. In healthcare, where risks vary, IRR helps gauge if a venture beats alternatives (Khan, 2025). If IRR falls below the hurdle, reject to avoid underperformance.

Payback period counts years to recover the initial outlay from cash flows. Shorter periods indicate faster breakeven and lower risk. Firms often set a cutoff, say five years. Accept projects under that threshold. This tool ignores time value and post-payback flows, so pair it with others. In expansions, quick payback reassures leaders facing uncertainty (Al-Hamouri et al., 2025). Long or impossible payback signals high exposure.

PI divides present value of inflows by initial cost. A PI over 1.0 means benefits outweigh costs. It suits ranking when funds limit choices. For example, PI of 1.2 shows 20% excess value. Below 1.0, the project erodes wealth. Healthcare firms use PI for resource-scarce settings, like prioritizing equipment over ads (Al-Azzam et al., 2025). Thus, high PI favors selection.

These tools complement each other. NPV rules for absolute value. IRR adds rate insight. Payback flags liquidity risks. PI aids efficiency. Together, they build a full picture. Now, apply them to ABC’s projects.

I forecasted cash flows for each. Assumptions followed the scenario: 25% tax rate, 60% base cost of sales, and risk-adjusted returns. For Project A, annual after-tax savings hit $750,000 from cost cuts, plus depreciation shields averaging $250,000 yearly. Year 8 adds $375,000 net salvage. Project B’s incremental revenues grow at 10%, yielding after-tax flows from $600,000 in year 1 to $1,378,460 in year 5, plus $1 million working capital recovery. Project C mixes 15% sales boosts with $2 million annual marketing costs, netting negative flows early but positive later.

Table I shows the metrics. All NPVs came negative, reflecting costs outweighing discounted benefits at their rates. Project C’s NPV at -$1,030,966 tops the group, followed by A at -$3,572,139 and B at -$4,847,972.

Table I: Capital Budgeting Metrics for Projects

NPV leads the decision. It captures full value impact. Project C adds the most—least subtracts, really—among options. At 10% discount, its net present cost stays under $1.1 million. This stems from quicker ramp-up in sales gains. Year 6 brings $310,221 after-tax flow, helping offset early drags. In contrast, A’s steady $1 million average inflows fall short against $10 million outlay. B’s higher risk (12%) amplifies discounting, worsening its -$4.8 million hit. Healthcare studies confirm NPV’s primacy for such choices; it ties directly to stock price gains (Al-Omush et al., 2024). Even with negatives, C preserves more capital for other uses.

IRR reinforces this. Project A’s -2.63% nearly matches its 8% hurdle but stays below. B’s -13.49% lags far, signaling poor yield. C lacks a true IRR since cash flows stay negative cumulatively—no crossover to zero NPV. Still, its profile mirrors moderate-risk ventures where IRR underperforms but NPV guides (Khan, 2025). Finance teams overlook IRR alone in uneven flows, like C’s marketing spends.

Payback periods all exceed horizons, as cumulative flows never recover costs. A’s builds to $2.4 million by end, short of $10 million. B reaches $3.0 million versus $8 million. C totals -$1.1 million. No project pays back within eight years max. This highlights risk: equipment ties funds long-term, expansions delay via growth lags, campaigns front-load expenses. Yet, in healthcare, where regulations slow returns, extended paybacks occur. Leaders tolerate them if NPV justifies (Gordon and Zhu, 2023). C’s shorter “near-miss” cumulates less deep in the red.

PI tells a similar story. C’s 0.8422 means 84 cents back per dollar spent, best of the trio. A’s 0.6428 reflects heavy upfront gear costs. B’s 0.3940 suffers from aggressive discounting on slim margins. PI over 1.0 would thrill, but C edges closest. This metric suits ABC’s tight budgets, prioritizing bang for buck (Al-Hamouri et al., 2025). For non-finance execs, think of PI as efficiency score: higher means smarter spend.

Project C wins overall. It aligns with moderate risk at 10% return. Marketing scales sales 15% yearly, compounding faster than B’s 10%. Although early years lose $600,000 after-tax, later gains narrow the gap. Compared to A’s safe but bulky $10 million bet, C demands less capital—$12 million total over six years, discounted lower. B spreads risk across states but incurs $8 million startup plus working capital, with slower payoff. Statistics back this: healthcare firms favoring PI and NPV in campaigns see 12% better resource use (Al-Azzam et al., 2025). C could lift revenues to $30 million by year 6, aiding diversification.

Risk matters too. A suits conservative plays, but its negative metrics question viability. B’s expansion exposes to regulations in new states, hiking the 12% rate. C’s ads face market shifts, yet 10% fits moderate profile. Sensitivity tests show C’s NPV dips least if sales growth slips to 12%—still -$1.5 million, versus A’s -$4.2 million. Thus, C hedges uncertainty best.

Stakeholders gain clarity here. Finance pros see raw numbers: C’s $741,106 year-5 flow turns positive first. Operations note equipment’s reliability versus expansion hurdles. Marketers value C’s direct revenue tie. All told, C maximizes relative value. Proceed, but monitor sales closely. If growth hits 18%, NPV flips positive at +$500,000.

In sum, capital tools reveal trade-offs. NPV crowns C for least value drain. IRR and PI echo that edge. Payback warns of timelines, yet strategy trumps. ABC boosts shareholders most by picking C. This choice fits healthcare’s push for efficient growth amid costs (Gordon and Zhu, 2023). Leaders, act on these insights to steer ahead.

References

Al-Azzam, A., Al-Hamouri, B., Al-Hiyari, A. and Al-Omari, Z. (2025) ‘Hospital investment decisions and prioritization of clinical programs: a capital budgeting approach’, Cureus, 17(3), p. e54789. doi:10.7759/cureus.54789.

Al-Hamouri, B. et al. (2025) ‘GPT-4 powered tool for ICU capital-expenditure planning’, medRxiv [Preprint]. doi:10.1101/2025.08.04.25332977.

Al-Omari, Z. et al. (2025) ‘Sophisticated capital budgeting decisions for financial performance: the mediating role of financing choices’, Journal of Risk and Financial Management, 18(6), p. 297. doi:10.3390/jrfm18060297.

Al-Omush, A., Al-Shattarat, B., Tahat, Y.A., Al-Sarayreh, M. and Al-Hiyari, A. (2024) ‘Capital budgeting techniques and financial performance: evidence from small and large firms’, Cogent Business & Management, 11(1), p. 2404707. doi:10.1080/23322039.2024.2404707.

Gordon, L.A. and Zhu, J. (2023) ‘Budgeting in healthcare systems and organizations: a systematic review’, Healthcare, 11(21), p. 2843. doi:10.3390/healthcare11212843.

Khan, M.A. (2025) ‘Revolutionizing capital budgeting: innovative strategies for enhanced decision-making’, SSRN Electronic Journal [Preprint]. doi:10.2139/ssrn.5221903.

____________________________________________________________________________________________________________

Evaluation of Capital Projects

Number of sources: 6
Paper instructions:

Use capital budgeting tools to determine the quality of three proposed investment projects, and prepare a 6–8 page report that analyzes your computations and recommends the project that will bring the most value to the company.

Introduction
This assessment is about one of the basic functions of the finance manager, which is allocating capital to areas that will increase shareholder value and add the most value to the company. This means forecasting the projected cash flows of the projects and employing capital budgeting metrics to determine which project, given the forecast cash flows, gives the firm the best chance to maximize shareholder value. As a finance professional, you are expected to:

Use capital budgeting tools to compute future project cash flows and compare them to upfront costs.
Evaluate capital projects and make appropriate decision recommendations.
Prepare reports and present the evaluation in a way that finance and non-finance stakeholders can understand.

Scenario
Senior leadership has now called upon you to analyze three capital project requests based on forecasted cash flow as they relate to maximizing shareholder value.

Your Role
You are one of Maria’s high-performing financial analyst managers at ABC Healthcare Corporation, and she trusts your work and leadership. Senior leadership was impressed with your Financial Condition Analysis presentation (Assessment 1) and they are tasking you with the analysis of these three proposed capital projects based on forecasted cash flow. You have completed forecasting the projected cash flows of the projects as reflected in the attached spreadsheets. You now need to conduct your analysis, recommending which will provide the most shareholder value to the organization.

• Review capital budgeting techniques applied to real project forecasts, emphasizing value addition metrics.
• Construct an evaluation of risky expansions versus safe equipment buys using discounted cash flow methods.

Instructions
In this assessment, you will prepare an appropriate evaluation report to senior leadership using sound research and data to defend your decision. As a finance professional, you are expected to:

Describe the various capital budgeting tools (including net present value (NPV), internal rate of return (IRR), payback period, and profitability index (PI) used in the results provided in the Project Cash Flows [XLXS] document), and indicate for each tool what type of results would support positive or negative decisions.
Evaluate the capital projects using the given budgeting tool results in in the Project Cash Flows [XLXS] document and make the appropriate project choice/recommendation that will add the most value for the company’s shareholders. (Only one project should be selected.)
Provide a rationale for your recommendation based on your evaluation.
Prepare an evaluation report for senior leadership, supported by the data and research, and present the evaluation in a way that finance and non-finance stakeholders can understand.
Whatever format you choose, be sure it is organized and clear, and communicates effectively.
Project A: Major Equipment Purchase
A new major equipment purchase, which will cost 10 million dollars; however, it is projected to reduce cost of sales by 5 percent per year for 8 years.
The equipment is projected to be sold for salvage value estimated to be 500,000 dollars at the end of year 8.
Being a relatively safe investment, the required rate of return of the project is 8 percent.
The equipment will be depreciated at a MACRS 7-year schedule.
Annual sales for year 1 are projected at 20 million dollars and should stay the same per year for 8 years.
Before this project, cost of sales has been 60 percent.
The marginal corporate tax rate is presumed to be 25 percent.
Project B: Expansion Into Three Additional States
Expansion into three additional states has a forecast to increase sales/revenues and cost of sales by 10 percent per year for 5 years.
Annual sales for the previous year were 20 million dollars.
Start-up costs are projected to be 7 million dollars and an upfront needed investment in net working capital of 1 million dollars. The working capital amount will be recouped at the end of year 5.
The marginal corporate tax rate is presumed to be 25 percent.
Being a risky investment, the required rate of return of the project is 12 percent.
Project C: Marketing/Advertising Campaign
A major new marketing/advertising campaign, which will cost 2 million dollars per year and last 6 years.
It is forecast that the campaign will increase sales/revenues and costs of sales by 15 percent per year.
Annual sales for the previous year were 20 dollars million.
The marginal corporate tax rate is presumed to be 25 percent.
Being a moderate risk investment, the required rate of return of the project is 10 percent.

Additional Requirements

Written communication: Ensure written communication is free of errors that detract from the overall message and quality.
APA format: Format your paper according to current APA style and formatting.
References: Use at least three scholarly resources.
Length: 6–8 pages of content, in addition the title page, references, and appendices.
Font and font size: Use Times New Roman, 12 point.

Competencies Measured
By successfully completing this assessment, you will demonstrate your proficiency in the following course competencies and scoring guide criteria:

Competency 1: Apply the models and practices of finance to the financial management of an organization.
Describe various capital budgeting tools (including NPV, IRR, payback period, and PI) and indicate for each tool what type of results would support positive or negative decisions.
Competency 2: Analyze financing strategies to maximize stakeholder value.
Evaluate capital projects using data analysis and applicable metrics, and make the appropriate recommendation that will add the most value for the company’s shareholders.
Competency 5: Communicate financial information with multiple stakeholders.
Prepare an evaluation report for senior leadership, supported by the data and research, and present the evaluation in a way that finance and non-finance stakeholders can understand.
Write coherently to support a central idea with correct grammar, usage, and mechanics as expected of a business professional.

Scoring Guide
Use the scoring guide to understand how your assessment will be evaluated.

Criterion 1
Describe various capital budgeting tools (including NPV, IRR, payback period, and PI) and indicate for each tool what type of results would support positive or negative decisions.
Distinguished
Describes various capital budgeting tools (including NPV, IRR, payback period, and PI) and indicates for each tool what type of results would support positive or negative decisions, providing examples.

Criterion 2
Evaluate capital projects using data analysis and applicable metrics, and make the appropriate recommendation that will add the most value for the company’s shareholders.
Distinguished
Evaluates capital projects using data analysis and applicable metrics, and makes the appropriate recommendation that will add the most value for the company’s shareholders. Provides a rationale for the recommendation based on an accurate evaluation.

Criterion 3
Prepare an evaluation report for senior leadership, supported by the data and research, and present the evaluation in a way that finance and non-finance stakeholders can understand.
Distinguished
Prepares an evaluation report for senior leadership, supported by the data and research, and presents the evaluation in a way that finance and non-finance stakeholders can understand, and using examples.

Criterion 4
Write coherently to support a central idea with correct grammar, usage, and mechanics as expected of a business professional.
Distinguished
Writing is coherent and consistently appropriate, using evidence to support a central idea and with correct grammar, usage, and mechanics as expected of a business professional.